136 related articles for article (PubMed ID: 10983731)
1. The potential role of antisense oligodeoxynucleotide therapy for cardiovascular disease.
Phillips MI; Galli SM; Mehta JL
Drugs; 2000 Aug; 60(2):239-48. PubMed ID: 10983731
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy for hypertension: sense and antisense strategies.
Phillips MI
Expert Opin Biol Ther; 2001 Jul; 1(4):655-62. PubMed ID: 11727501
[TBL] [Abstract][Full Text] [Related]
3. Somatic gene therapy for hypertension.
Phillips MI
Braz J Med Biol Res; 2000 Jun; 33(6):715-21. PubMed ID: 10829100
[TBL] [Abstract][Full Text] [Related]
4. Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension.
Phillips MI
Hypertension; 1997 Jan; 29(1 Pt 2):177-87. PubMed ID: 9039099
[TBL] [Abstract][Full Text] [Related]
5. Critical role of AT1 receptor expression after ischemia/reperfusion in isolated rat hearts: beneficial effect of antisense oligodeoxynucleotides directed at AT1 receptor mRNA.
Yang BC; Phillips MI; Zhang YC; Kimura B; Shen LP; Mehta P; Mehta JL
Circ Res; 1998 Sep; 83(5):552-9. PubMed ID: 9734478
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy for hypertension: antisense inhibition of the renin-angiotensin system.
Phillips MI; Kimura B
Methods Mol Med; 2005; 108():363-79. PubMed ID: 16028695
[TBL] [Abstract][Full Text] [Related]
7. Antisense oligonucleotides strategy in the treatment of hypertension.
Kagiyama S; Kagiyama T; Phillips MI
Curr Opin Mol Ther; 2001 Jun; 3(3):258-64. PubMed ID: 11497350
[TBL] [Abstract][Full Text] [Related]
8. Protection against ischemia/reperfusion injury and myocardial dysfunction by antisense-oligodeoxynucleotide directed at angiotensin-converting enzyme mRNA.
Chen H; Mohuczy D; Li D; Kimura B; Phillips MI; Mehta P; Mehta JL
Gene Ther; 2001 May; 8(10):804-10. PubMed ID: 11420645
[TBL] [Abstract][Full Text] [Related]
9. Antisense inhibition of hypertension: a new strategy for renin-angiotensin candidate genes.
Phillips MI; Wielbo D; Gyurko R
Kidney Int; 1994 Dec; 46(6):1554-6. PubMed ID: 7700004
[TBL] [Abstract][Full Text] [Related]
10. Myocardial angiotensin II receptor expression and ischemia-reperfusion injury.
Yang B; Li D; Phillips MI; Mehta P; Mehta JL
Vasc Med; 1998; 3(2):121-30. PubMed ID: 9796075
[TBL] [Abstract][Full Text] [Related]
11. Vigilant vector: heart-specific promoter in an adeno-associated virus vector for cardioprotection.
Phillips MI; Tang Y; Schmidt-Ott K; Qian K; Kagiyama S
Hypertension; 2002 Feb; 39(2 Pt 2):651-5. PubMed ID: 11882625
[TBL] [Abstract][Full Text] [Related]
12. Prolonged reduction of high blood pressure with an in vivo, nonpathogenic, adeno-associated viral vector delivery of AT1-R mRNA antisense.
Phillips MI; Mohuczy-Dominiak D; Coffey M; Galli SM; Kimura B; Wu P; Zelles T
Hypertension; 1997 Jan; 29(1 Pt 2):374-80. PubMed ID: 9039130
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy for hypertension: the preclinical data.
Phillips MI
Methods Enzymol; 2002; 346():3-13. PubMed ID: 11883075
[TBL] [Abstract][Full Text] [Related]
14. Time course of inhibition of hypertension by antisense oligonucleotides targeted to AT1 angiotensin receptor mRNA in spontaneously hypertensive rats.
Gyurko R; Tran D; Phillips MI
Am J Hypertens; 1997 May; 10(5 Pt 2):56S-62S. PubMed ID: 9160782
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of hypertension and heart hypertrophy by adeno-associated virus delivering angiotensinogen antisense.
Kimura B; Mohuczy D; Tang X; Phillips MI
Hypertension; 2001 Feb; 37(2 Pt 2):376-80. PubMed ID: 11230303
[TBL] [Abstract][Full Text] [Related]
16. Protection against myocardial dysfunction induced by global ischemia-reperfusion by antisense-oligodeoxynucleotides directed at beta(1)-adrenoceptor mRNA.
Chen H; Zhang YC; Li D; Phillips MI; Mehta P; Shi M; Mehta JL
J Pharmacol Exp Ther; 2000 Aug; 294(2):722-7. PubMed ID: 10900253
[TBL] [Abstract][Full Text] [Related]
17. Prolonged attenuation of cold-induced hypertension by adenoviral delivery of renin antisense.
Wang X; Sun Z; Cade R
Kidney Int; 2005 Aug; 68(2):680-7. PubMed ID: 16014045
[TBL] [Abstract][Full Text] [Related]
18. Recombinant adeno-associated virus-mediated delivery of antisense angiotensin II receptor 1 gene attenuates hypertension development.
Li XG; Yan JT; Xu XZ; Wang JN; Cheng LM; Wang T; Zuo P; Wang DW
Acta Pharmacol Sin; 2007 Nov; 28(11):1737-45. PubMed ID: 17959024
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of hypertension by peripheral administration of antisense oligodeoxynucleotides.
Wielbo D; Simon A; Phillips MI; Toffolo S
Hypertension; 1996 Jul; 28(1):147-51. PubMed ID: 8675256
[TBL] [Abstract][Full Text] [Related]
20. Fusigenic viral liposome for gene therapy in cardiovascular diseases.
Dzau VJ; Mann MJ; Morishita R; Kaneda Y
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11421-5. PubMed ID: 8876150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
